“I must say i feel we are in need of the human data.” — Pablo Sanchez, MD, of the CDC’s Advisory Committee on Immunization Practices, who cast the only real vote against recommending the new bivalent boosters because of the insufficient clinical trial data.
“It might cause a large amount of anxiety in people.” — Sean McGann, MD, a crisis physician at Thomas Jefferson University Hospital in Philadelphia, on people’s Apple watches pinging wearers about arrhythmia alerts.
“Already six falls transported to Mercy trauma — one in bad shape.” — Chris Van Gorder, Scripps Health CEO, on people injured while jumping or falling off the border wall from Mexico in attempts to climb in to the U.S.
“You largely are hooked into that ancestral strain, so it is hard to improve in a large way with BA.4/5 vaccines.” — Paul Offit, MD, of Children’s Hospital of Philadelphia, on COVID booster shots.
“It just hasn’t existed before.” — Clese Erikson, MPAff, of George Washington University, on a fresh database that mapped the U.S. behavioral health workforce.
“These results claim that black tea, even at higher degrees of intake, could be part of a healthy diet plan.” — Maki Inoue-Choi, PhD, of the National Cancer Institute, on new research showing individuals who drank at the very least two glasses of tea each day had a slightly lower threat of death.
“It’s truly unfortunate that pregnant folks are not contained in trials of new medications because it is hard to learn if they are safe to utilize in pregnancy.” — Kunjal Patel, DSc, of the Harvard T.H. Chan School of Public Health in Boston, on the agent dolutegravir (Tivicay) showing greater viral suppression for pregnant patients with HIV-1 than other therapies.
“Our study brings forth another impact of low testosterone: decreased capability to overcome a sickness such as for example COVID-19.” — Sandeep Dhindsa, MD, of St. Louis University School of Medicine in Missouri, on higher COVID-related hospitalization rates seen among men with hypogonadism.